MAXIBOLIN Drug Patent Profile
✉ Email this page to a colleague
When do Maxibolin patents expire, and when can generic versions of Maxibolin launch?
Maxibolin is a drug marketed by Organon Usa Inc and is included in two NDAs.
The generic ingredient in MAXIBOLIN is ethylestrenol. Additional details are available on the ethylestrenol profile page.
Summary for MAXIBOLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 12 |
Patent Applications: | 992 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MAXIBOLIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MAXIBOLIN
US Patents and Regulatory Information for MAXIBOLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Usa Inc | MAXIBOLIN | ethylestrenol | ELIXIR;ORAL | 014006-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Organon Usa Inc | MAXIBOLIN | ethylestrenol | TABLET;ORAL | 014005-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |